Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.06.24	Johnson & Johnson Reports Long-term Data From Phase 1/2 Study With TALVEY (RTTNews)
28.05.24	Johnson & Johnson To Acquire Rights To Numab Therapeutics' Clinical-Stage Bispecific Antibody NM26 (RTTNews)
16.05.24	Johnson & Johnson To Acquire Proteologix For $850 Mln (RTTNews)
01.05.24	J&J Proposes $6.475 Bln To Settle Ovarian Cancer Lawsuits (RTTNews)
26.04.24	JNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLC (RTTNews)
16.04.24	Johnson & Johnson Updates FY24 Earnings, Sales Outlook - Update (RTTNews)
16.04.24	Genmab's Q1 Darzalex Sales By Johnson & Johnson Reach $2.692 Bln (RTTNews)
16.04.24	Johnson & Johnson Q1 Earnings Summary (RTTNews)
05.04.24	Johnson & Johnson To Buy Shockwave In $13.1 Bln Deal (RTTNews)
28.03.24	J&J Agrees To Pay $75 Mln In Mississippi's Baby Powder Case (RTTNews)
07.03.24	Johnson & Johnson Buys Ambrx Biopharma In $2 Bln Cash Deal (RTTNews)
06.03.24	J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma (RTTNews)
01.03.24	Johnson & Johnson's Rybrevant Gets FDA Approval For Lung Cancer Treatment (RTTNews)
28.02.24	Biotech Stocks Facing FDA Decision In March 2024 (RTTNews)
23.02.24	Janssen Pharma's Carvykti Gets Positive CHMP Opinion For Earlier Multiple Myeloma Treatment (RTTNews)
24.01.24	JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims (RTTNews)
23.01.24	Johnson & Johnson Backs FY24 Earnings View, Sales To Rise (RTTNews)
23.01.24	Johnson & Johnson Q4 Profit Increases, beats estimates (RTTNews)
08.01.24	Johnson & Johnson To Acquire Ambrx For $28.00 Per Share - Quick Facts (RTTNews)
26.12.23	LianBio Transfers Rights For NBTXR3 In China And Other Asian Markets To Janssen Pharma; Stock Up (RTTNews)
15.12.23	AC Immune Advances Anti-pTau Active Immunotherapy For Alzheimer's Disease Into Phase 2b Trial (RTTNews)
13.12.23	Integra LifeSciences To Acquire Acclarent For $275 Mln Cash (RTTNews)
07.12.23	Vanda Pharmaceuticals Acquires U.S., Canadian Rights To PONVORY From Janssen (RTTNews)
05.12.23	Johnson & Johnson Guides FY24 Adj. EPS Below Estimates (RTTNews)
30.11.23	Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 (RTTNews)
17.10.23	Johnson & Johnson Lifts 2023 Guidance Midpoints For Sales, Adj. EPS (RTTNews)
17.10.23	Johnson & Johnson Q3 Profit Beats Estimates (RTTNews)
08.10.23	J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder (RTTNews)
15.09.23	Johnson & Johnson Unveils Modernized Logo After 135 Years (RTTNews)
08.09.23	Janssen Pharma Submits Marketing Authorisation Application For Erdafitinib (RTTNews)
06.09.23	Idorsia In Deal With JNJ's Janssen Biotech For Return Of Rights For Aprocitentan; Stock Down (RTTNews)
30.08.23	Johnson & Johnson Trims FY23 Earnings, Net Sales Outlook (RTTNews)
29.08.23	Initial Medications Chosen By HHS For Medicare Drug Price Negotiations (RTTNews)
22.08.23	Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 (PR Newswire)
10.08.23	JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma (RTTNews)
10.08.23	Kenvue To Join S&P 500 (RTTNews)
10.08.23	Kenvue Set to Join S&P 500 (PR Newswire)
24.07.23	Johnson & Johnson Launches Exchange Offer To Separate Kenvue (RTTNews)
20.07.23	Johnson & Johnson Rises On Upbeat Quarterly Results, Outlook (RTTNews)
20.07.23	Johnson & Johnson Raises Guidance For 2023 Adj. Operational EPS, Adj. Operational Sales (RTTNews)
20.07.23	Johnson & Johnson Q2 Profit Increases, beats estimates (RTTNews)
19.07.23	Johnson & Johnson Sues HHS Over Medicare Drug Price Negotiation Program (RTTNews)
10.07.23	Nanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Market (RTTNews)
06.06.23	Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration (RTTNews)
21.04.23	Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement (PR Newswire)
18.04.23	Johnson & Johnson Q1 Profit Tops Estimates; Raises 2023 Guidance Midpoints (RTTNews)
18.04.23	Johnson & Johnson Q1 Earnings Summary (RTTNews)
04.04.23	Johnson & Johnson To Set Aside $8.9 Bln To Resolve Talc-based Cancer Lawsuits (RTTNews)
22.03.23	Talc Plaintiffs Will Press to Reopen Courthouse Doors (PR Newswire)
13.02.23	Alcon, J&J Surgical To Settle Litigation On Femtosecond Laser Assisted Cataract Surgery Devices (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
21.11.24		Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester
21.11.24		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
21.11.24		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
21.11.24		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
21.11.24		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
21.11.24		SLI aktuell: Anleger lassen SLI letztendlich steigen

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

21.11.24

Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester

21.11.24

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

21.11.24

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

21.11.24

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

21.11.24

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone